This is a preview of subscription content, log in via an institution to check access.
Notes
2018 US dollars
Reference
Gaziano TA, et al. Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States. American Heart Journal 214: 77-87, 7 May 2019. Available from: URL: http://doi.org/10.1016/j.ahj.2019.04.020
Rights and permissions
About this article
Cite this article
Polypills cost effective for secondary prevention of CVD. PharmacoEcon Outcomes News 831, 24 (2019). https://doi.org/10.1007/s40274-019-6012-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6012-5